nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—Toremifene—breast cancer	0.248	0.614	CrCtD
Orphenadrine—Tamoxifen—breast cancer	0.155	0.386	CrCtD
Orphenadrine—SCN10A—breast cancer	0.12	0.791	CbGaD
Orphenadrine—CYP3A4—breast cancer	0.0316	0.209	CbGaD
Orphenadrine—Bedaquiline—Toremifene—breast cancer	0.0293	0.115	CrCrCtD
Orphenadrine—Bedaquiline—Tamoxifen—breast cancer	0.0184	0.0721	CrCrCtD
Orphenadrine—CYP2B6—Thiotepa—breast cancer	0.0156	0.133	CbGbCtD
Orphenadrine—Naftifine—Toremifene—breast cancer	0.0147	0.0574	CrCrCtD
Orphenadrine—Cloperastine—Raloxifene—breast cancer	0.014	0.0546	CrCrCtD
Orphenadrine—Tamoxifen—Toremifene—breast cancer	0.0122	0.0477	CrCrCtD
Orphenadrine—Toremifene—Tamoxifen—breast cancer	0.0111	0.0436	CrCrCtD
Orphenadrine—CYP2B6—Raloxifene—breast cancer	0.0104	0.0885	CbGbCtD
Orphenadrine—Doxylamine—Toremifene—breast cancer	0.0102	0.0399	CrCrCtD
Orphenadrine—Phenoxybenzamine—Toremifene—breast cancer	0.00967	0.0379	CrCrCtD
Orphenadrine—Dextropropoxyphene—Toremifene—breast cancer	0.00967	0.0379	CrCrCtD
Orphenadrine—Naftifine—Tamoxifen—breast cancer	0.00922	0.0361	CrCrCtD
Orphenadrine—Bromodiphenhydramine—Toremifene—breast cancer	0.00861	0.0337	CrCrCtD
Orphenadrine—CYP3A4—Exemestane—breast cancer	0.00835	0.0709	CbGbCtD
Orphenadrine—Methadyl Acetate—Tamoxifen—breast cancer	0.0074	0.029	CrCrCtD
Orphenadrine—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0074	0.029	CrCrCtD
Orphenadrine—CYP3A4—Letrozole—breast cancer	0.0071	0.0603	CbGbCtD
Orphenadrine—Clofedanol—Toremifene—breast cancer	0.00699	0.0274	CrCrCtD
Orphenadrine—CYP2E1—Tamoxifen—breast cancer	0.00698	0.0593	CbGbCtD
Orphenadrine—Cyclobenzaprine—Tamoxifen—breast cancer	0.00696	0.0272	CrCrCtD
Orphenadrine—CYP2B6—Tamoxifen—breast cancer	0.00689	0.0585	CbGbCtD
Orphenadrine—CYP2E1—Mitoxantrone—breast cancer	0.00681	0.0578	CbGbCtD
Orphenadrine—Benzphetamine—Toremifene—breast cancer	0.00677	0.0265	CrCrCtD
Orphenadrine—Doxylamine—Tamoxifen—breast cancer	0.0064	0.025	CrCrCtD
Orphenadrine—CYP3A4—Anastrozole—breast cancer	0.00633	0.0538	CbGbCtD
Orphenadrine—Benzyl Benzoate—Toremifene—breast cancer	0.00627	0.0245	CrCrCtD
Orphenadrine—Phenoxybenzamine—Tamoxifen—breast cancer	0.00608	0.0238	CrCrCtD
Orphenadrine—Dextropropoxyphene—Tamoxifen—breast cancer	0.00608	0.0238	CrCrCtD
Orphenadrine—Diphenhydramine—Toremifene—breast cancer	0.00601	0.0235	CrCrCtD
Orphenadrine—CYP3A4—Toremifene—breast cancer	0.00579	0.0492	CbGbCtD
Orphenadrine—Tripelennamine—Tamoxifen—breast cancer	0.00579	0.0226	CrCrCtD
Orphenadrine—Dimetacrine—Tamoxifen—breast cancer	0.00541	0.0212	CrCrCtD
Orphenadrine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.00541	0.0212	CrCrCtD
Orphenadrine—CYP3A4—Fulvestrant—breast cancer	0.00538	0.0457	CbGbCtD
Orphenadrine—CYP2B6—Irinotecan—breast cancer	0.00529	0.0449	CbGbCtD
Orphenadrine—Methadone—Tamoxifen—breast cancer	0.00508	0.0199	CrCrCtD
Orphenadrine—CYP3A4—Thiotepa—breast cancer	0.0048	0.0407	CbGbCtD
Orphenadrine—Clofedanol—Tamoxifen—breast cancer	0.00439	0.0172	CrCrCtD
Orphenadrine—CYP3A4—Ixabepilone—breast cancer	0.00439	0.0373	CbGbCtD
Orphenadrine—Benzphetamine—Tamoxifen—breast cancer	0.00425	0.0166	CrCrCtD
Orphenadrine—CYP3A4—Lapatinib—breast cancer	0.00422	0.0359	CbGbCtD
Orphenadrine—Promazine—Tamoxifen—breast cancer	0.00406	0.0159	CrCrCtD
Orphenadrine—Benzyl Benzoate—Tamoxifen—breast cancer	0.00394	0.0154	CrCrCtD
Orphenadrine—Diphenhydramine—Tamoxifen—breast cancer	0.00378	0.0148	CrCrCtD
Orphenadrine—CYP3A4—Raloxifene—breast cancer	0.0032	0.0272	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—breast cancer	0.00289	0.0245	CbGbCtD
Orphenadrine—CYP3A4—Vinorelbine—breast cancer	0.00234	0.0199	CbGbCtD
Orphenadrine—CYP3A4—Tamoxifen—breast cancer	0.00212	0.018	CbGbCtD
Orphenadrine—CYP3A4—Mitoxantrone—breast cancer	0.00206	0.0175	CbGbCtD
Orphenadrine—CYP3A4—Paclitaxel—breast cancer	0.00165	0.014	CbGbCtD
Orphenadrine—CYP3A4—Irinotecan—breast cancer	0.00162	0.0138	CbGbCtD
Orphenadrine—CYP3A4—Vinblastine—breast cancer	0.00144	0.0123	CbGbCtD
Orphenadrine—CYP3A4—Docetaxel—breast cancer	0.00119	0.0101	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—breast cancer	0.000887	0.00753	CbGbCtD
Orphenadrine—Tamoxifen—ESRRA—breast cancer	0.00014	0.0776	CrCbGaD
Orphenadrine—SCN9A—pituitary gland—breast cancer	0.00013	0.0487	CbGeAlD
Orphenadrine—SCN9A—adipose tissue—breast cancer	0.00013	0.0485	CbGeAlD
Orphenadrine—GRIN1—endocrine gland—breast cancer	0.000129	0.0481	CbGeAlD
Orphenadrine—SCN9A—adrenal gland—breast cancer	0.000116	0.0435	CbGeAlD
Orphenadrine—SCN4A—pituitary gland—breast cancer	0.000116	0.0434	CbGeAlD
Orphenadrine—SCN4A—adipose tissue—breast cancer	0.000116	0.0432	CbGeAlD
Orphenadrine—Dimetacrine—ACHE—breast cancer	0.000113	0.0624	CrCbGaD
Orphenadrine—Dizziness—Letrozole—breast cancer	0.00011	0.00361	CcSEcCtD
Orphenadrine—Dizziness—Anastrozole—breast cancer	0.00011	0.00361	CcSEcCtD
Orphenadrine—Confusional state—Goserelin—breast cancer	0.000109	0.0036	CcSEcCtD
Orphenadrine—Tachycardia—Melphalan—breast cancer	0.000109	0.00357	CcSEcCtD
Orphenadrine—Anaphylactic shock—Goserelin—breast cancer	0.000109	0.00357	CcSEcCtD
Orphenadrine—Skin disorder—Melphalan—breast cancer	0.000108	0.00355	CcSEcCtD
Orphenadrine—Vision blurred—Thiotepa—breast cancer	0.000107	0.00352	CcSEcCtD
Orphenadrine—Tamoxifen—SULT1A1—breast cancer	0.000106	0.0588	CrCbGaD
Orphenadrine—Tachycardia—Goserelin—breast cancer	0.000106	0.00348	CcSEcCtD
Orphenadrine—Vomiting—Letrozole—breast cancer	0.000106	0.00347	CcSEcCtD
Orphenadrine—Vomiting—Anastrozole—breast cancer	0.000106	0.00347	CcSEcCtD
Orphenadrine—Skin disorder—Goserelin—breast cancer	0.000105	0.00346	CcSEcCtD
Orphenadrine—Palpitations—Vinorelbine—breast cancer	0.000105	0.00346	CcSEcCtD
Orphenadrine—Feeling abnormal—Chlorambucil—breast cancer	0.000105	0.00346	CcSEcCtD
Orphenadrine—Aplastic anaemia—Methotrexate—breast cancer	0.000105	0.00345	CcSEcCtD
Orphenadrine—Nausea—Ixabepilone—breast cancer	0.000105	0.00344	CcSEcCtD
Orphenadrine—Agitation—Thiotepa—breast cancer	0.000105	0.00343	CcSEcCtD
Orphenadrine—Dizziness—Raloxifene—breast cancer	0.000104	0.00342	CcSEcCtD
Orphenadrine—Headache—Letrozole—breast cancer	0.000104	0.00342	CcSEcCtD
Orphenadrine—Headache—Anastrozole—breast cancer	0.000104	0.00342	CcSEcCtD
Orphenadrine—SCN4A—adrenal gland—breast cancer	0.000104	0.0388	CbGeAlD
Orphenadrine—Urticaria—Chlorambucil—breast cancer	0.000101	0.00333	CcSEcCtD
Orphenadrine—KCNH2—nipple—breast cancer	0.000101	0.0379	CbGeAlD
Orphenadrine—Vomiting—Idarubicin—breast cancer	0.0001	0.00329	CcSEcCtD
Orphenadrine—Vomiting—Raloxifene—breast cancer	0.0001	0.00329	CcSEcCtD
Orphenadrine—Constipation—Vinblastine—breast cancer	0.0001	0.00329	CcSEcCtD
Orphenadrine—SCN10A—pituitary gland—breast cancer	9.9e-05	0.037	CbGeAlD
Orphenadrine—Headache—Raloxifene—breast cancer	9.88e-05	0.00324	CcSEcCtD
Orphenadrine—Headache—Idarubicin—breast cancer	9.88e-05	0.00324	CcSEcCtD
Orphenadrine—Nausea—Letrozole—breast cancer	9.87e-05	0.00324	CcSEcCtD
Orphenadrine—Nausea—Anastrozole—breast cancer	9.87e-05	0.00324	CcSEcCtD
Orphenadrine—Aplastic anaemia—Epirubicin—breast cancer	9.84e-05	0.00323	CcSEcCtD
Orphenadrine—Anaphylactic shock—Vinorelbine—breast cancer	9.73e-05	0.00319	CcSEcCtD
Orphenadrine—Constipation—Tamoxifen—breast cancer	9.72e-05	0.00319	CcSEcCtD
Orphenadrine—Somnolence—Goserelin—breast cancer	9.65e-05	0.00317	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinblastine—breast cancer	9.64e-05	0.00317	CcSEcCtD
Orphenadrine—Tachycardia—Vinorelbine—breast cancer	9.49e-05	0.00312	CcSEcCtD
Orphenadrine—Skin disorder—Vinorelbine—breast cancer	9.45e-05	0.0031	CcSEcCtD
Orphenadrine—Hypersensitivity—Chlorambucil—breast cancer	9.41e-05	0.00309	CcSEcCtD
Orphenadrine—Nausea—Raloxifene—breast cancer	9.37e-05	0.00308	CcSEcCtD
Orphenadrine—Nausea—Idarubicin—breast cancer	9.37e-05	0.00308	CcSEcCtD
Orphenadrine—Confusional state—Thiotepa—breast cancer	9.37e-05	0.00308	CcSEcCtD
Orphenadrine—Constipation—Goserelin—breast cancer	9.29e-05	0.00305	CcSEcCtD
Orphenadrine—Vision blurred—Mitoxantrone—breast cancer	9.26e-05	0.00304	CcSEcCtD
Orphenadrine—Asthenia—Chlorambucil—breast cancer	9.16e-05	0.00301	CcSEcCtD
Orphenadrine—Aplastic anaemia—Doxorubicin—breast cancer	9.11e-05	0.00299	CcSEcCtD
Orphenadrine—Tachycardia—Thiotepa—breast cancer	9.06e-05	0.00298	CcSEcCtD
Orphenadrine—Pruritus—Chlorambucil—breast cancer	9.04e-05	0.00297	CcSEcCtD
Orphenadrine—Urticaria—Tamoxifen—breast cancer	9.03e-05	0.00297	CcSEcCtD
Orphenadrine—Skin disorder—Thiotepa—breast cancer	9.02e-05	0.00296	CcSEcCtD
Orphenadrine—Feeling abnormal—Goserelin—breast cancer	8.95e-05	0.00294	CcSEcCtD
Orphenadrine—Vision blurred—Fluorouracil—breast cancer	8.87e-05	0.00291	CcSEcCtD
Orphenadrine—Urticaria—Melphalan—breast cancer	8.84e-05	0.0029	CcSEcCtD
Orphenadrine—Urticaria—Goserelin—breast cancer	8.63e-05	0.00283	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinblastine—breast cancer	8.62e-05	0.00283	CcSEcCtD
Orphenadrine—Asthenia—Vinblastine—breast cancer	8.4e-05	0.00276	CcSEcCtD
Orphenadrine—Hypersensitivity—Tamoxifen—breast cancer	8.38e-05	0.00275	CcSEcCtD
Orphenadrine—Constipation—Vinorelbine—breast cancer	8.32e-05	0.00273	CcSEcCtD
Orphenadrine—Somnolence—Thiotepa—breast cancer	8.26e-05	0.00271	CcSEcCtD
Orphenadrine—Hypersensitivity—Melphalan—breast cancer	8.2e-05	0.00269	CcSEcCtD
Orphenadrine—Asthenia—Tamoxifen—breast cancer	8.16e-05	0.00268	CcSEcCtD
Orphenadrine—Vomiting—Chlorambucil—breast cancer	8.12e-05	0.00267	CcSEcCtD
Orphenadrine—HRH1—nipple—breast cancer	8.12e-05	0.0304	CbGeAlD
Orphenadrine—Confusional state—Irinotecan—breast cancer	8.09e-05	0.00266	CcSEcCtD
Orphenadrine—Confusional state—Mitoxantrone—breast cancer	8.09e-05	0.00266	CcSEcCtD
Orphenadrine—Pruritus—Tamoxifen—breast cancer	8.04e-05	0.00264	CcSEcCtD
Orphenadrine—Anaphylactic shock—Mitoxantrone—breast cancer	8.02e-05	0.00263	CcSEcCtD
Orphenadrine—Anaphylactic shock—Irinotecan—breast cancer	8.02e-05	0.00263	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinorelbine—breast cancer	8.01e-05	0.00263	CcSEcCtD
Orphenadrine—Hypersensitivity—Goserelin—breast cancer	8e-05	0.00263	CcSEcCtD
Orphenadrine—Asthenia—Melphalan—breast cancer	7.99e-05	0.00262	CcSEcCtD
Orphenadrine—Constipation—Thiotepa—breast cancer	7.94e-05	0.00261	CcSEcCtD
Orphenadrine—Pruritus—Melphalan—breast cancer	7.88e-05	0.00259	CcSEcCtD
Orphenadrine—Tension—Paclitaxel—breast cancer	7.87e-05	0.00258	CcSEcCtD
Orphenadrine—Tachycardia—Mitoxantrone—breast cancer	7.83e-05	0.00257	CcSEcCtD
Orphenadrine—Anaphylactic shock—Gemcitabine—breast cancer	7.81e-05	0.00257	CcSEcCtD
Orphenadrine—Asthenia—Goserelin—breast cancer	7.79e-05	0.00256	CcSEcCtD
Orphenadrine—Skin disorder—Mitoxantrone—breast cancer	7.79e-05	0.00256	CcSEcCtD
Orphenadrine—Confusional state—Fluorouracil—breast cancer	7.75e-05	0.00254	CcSEcCtD
Orphenadrine—Dizziness—Vinblastine—breast cancer	7.74e-05	0.00254	CcSEcCtD
Orphenadrine—Urticaria—Vinorelbine—breast cancer	7.73e-05	0.00254	CcSEcCtD
Orphenadrine—Pruritus—Goserelin—breast cancer	7.68e-05	0.00252	CcSEcCtD
Orphenadrine—Anaphylactic shock—Fluorouracil—breast cancer	7.68e-05	0.00252	CcSEcCtD
Orphenadrine—SCN10A—endocrine gland—breast cancer	7.67e-05	0.0287	CbGeAlD
Orphenadrine—Feeling abnormal—Thiotepa—breast cancer	7.65e-05	0.00251	CcSEcCtD
Orphenadrine—Skin disorder—Gemcitabine—breast cancer	7.59e-05	0.00249	CcSEcCtD
Orphenadrine—Nausea—Chlorambucil—breast cancer	7.59e-05	0.00249	CcSEcCtD
Orphenadrine—Vision blurred—Paclitaxel—breast cancer	7.55e-05	0.00248	CcSEcCtD
Orphenadrine—Dizziness—Tamoxifen—breast cancer	7.52e-05	0.00247	CcSEcCtD
Orphenadrine—Tremor—Paclitaxel—breast cancer	7.51e-05	0.00247	CcSEcCtD
Orphenadrine—Tachycardia—Fluorouracil—breast cancer	7.5e-05	0.00246	CcSEcCtD
Orphenadrine—Vomiting—Vinblastine—breast cancer	7.44e-05	0.00244	CcSEcCtD
Orphenadrine—Urticaria—Thiotepa—breast cancer	7.38e-05	0.00242	CcSEcCtD
Orphenadrine—Agitation—Paclitaxel—breast cancer	7.37e-05	0.00242	CcSEcCtD
Orphenadrine—Headache—Vinblastine—breast cancer	7.33e-05	0.00241	CcSEcCtD
Orphenadrine—Vomiting—Tamoxifen—breast cancer	7.23e-05	0.00237	CcSEcCtD
Orphenadrine—Dizziness—Goserelin—breast cancer	7.18e-05	0.00236	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinorelbine—breast cancer	7.17e-05	0.00235	CcSEcCtD
Orphenadrine—Somnolence—Mitoxantrone—breast cancer	7.13e-05	0.00234	CcSEcCtD
Orphenadrine—Somnolence—Irinotecan—breast cancer	7.13e-05	0.00234	CcSEcCtD
Orphenadrine—Headache—Tamoxifen—breast cancer	7.12e-05	0.00234	CcSEcCtD
Orphenadrine—Palpitations—Paclitaxel—breast cancer	7.08e-05	0.00233	CcSEcCtD
Orphenadrine—Vomiting—Melphalan—breast cancer	7.08e-05	0.00232	CcSEcCtD
Orphenadrine—Asthenia—Vinorelbine—breast cancer	6.98e-05	0.00229	CcSEcCtD
Orphenadrine—SCN9A—lymph node—breast cancer	6.96e-05	0.0261	CbGeAlD
Orphenadrine—Nausea—Vinblastine—breast cancer	6.95e-05	0.00228	CcSEcCtD
Orphenadrine—Somnolence—Gemcitabine—breast cancer	6.95e-05	0.00228	CcSEcCtD
Orphenadrine—Vomiting—Goserelin—breast cancer	6.9e-05	0.00227	CcSEcCtD
Orphenadrine—Pruritus—Vinorelbine—breast cancer	6.88e-05	0.00226	CcSEcCtD
Orphenadrine—Constipation—Irinotecan—breast cancer	6.86e-05	0.00225	CcSEcCtD
Orphenadrine—Constipation—Mitoxantrone—breast cancer	6.86e-05	0.00225	CcSEcCtD
Orphenadrine—Hypersensitivity—Thiotepa—breast cancer	6.84e-05	0.00225	CcSEcCtD
Orphenadrine—Somnolence—Fluorouracil—breast cancer	6.83e-05	0.00224	CcSEcCtD
Orphenadrine—Headache—Goserelin—breast cancer	6.8e-05	0.00223	CcSEcCtD
Orphenadrine—Nausea—Tamoxifen—breast cancer	6.75e-05	0.00222	CcSEcCtD
Orphenadrine—Constipation—Gemcitabine—breast cancer	6.68e-05	0.00219	CcSEcCtD
Orphenadrine—Asthenia—Thiotepa—breast cancer	6.66e-05	0.00219	CcSEcCtD
Orphenadrine—Nausea—Melphalan—breast cancer	6.61e-05	0.00217	CcSEcCtD
Orphenadrine—Feeling abnormal—Mitoxantrone—breast cancer	6.61e-05	0.00217	CcSEcCtD
Orphenadrine—Feeling abnormal—Irinotecan—breast cancer	6.61e-05	0.00217	CcSEcCtD
Orphenadrine—Confusional state—Paclitaxel—breast cancer	6.6e-05	0.00217	CcSEcCtD
Orphenadrine—Pruritus—Thiotepa—breast cancer	6.57e-05	0.00216	CcSEcCtD
Orphenadrine—Anaphylactic shock—Paclitaxel—breast cancer	6.54e-05	0.00215	CcSEcCtD
Orphenadrine—Cyclopentolate—BCHE—breast cancer	6.49e-05	0.0359	CrCbGaD
Orphenadrine—Nausea—Goserelin—breast cancer	6.45e-05	0.00212	CcSEcCtD
Orphenadrine—Feeling abnormal—Gemcitabine—breast cancer	6.44e-05	0.00211	CcSEcCtD
Orphenadrine—Dizziness—Vinorelbine—breast cancer	6.43e-05	0.00211	CcSEcCtD
Orphenadrine—Tachycardia—Paclitaxel—breast cancer	6.38e-05	0.0021	CcSEcCtD
Orphenadrine—Urticaria—Mitoxantrone—breast cancer	6.37e-05	0.00209	CcSEcCtD
Orphenadrine—Skin disorder—Paclitaxel—breast cancer	6.35e-05	0.00209	CcSEcCtD
Orphenadrine—Feeling abnormal—Fluorouracil—breast cancer	6.33e-05	0.00208	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—breast cancer	6.27e-05	0.00206	CcSEcCtD
Orphenadrine—Vision blurred—Capecitabine—breast cancer	6.2e-05	0.00204	CcSEcCtD
Orphenadrine—Vomiting—Vinorelbine—breast cancer	6.18e-05	0.00203	CcSEcCtD
Orphenadrine—Tremor—Capecitabine—breast cancer	6.16e-05	0.00202	CcSEcCtD
Orphenadrine—Dizziness—Thiotepa—breast cancer	6.14e-05	0.00202	CcSEcCtD
Orphenadrine—KCNH2—endometrium—breast cancer	6.11e-05	0.0229	CbGeAlD
Orphenadrine—Urticaria—Fluorouracil—breast cancer	6.1e-05	0.002	CcSEcCtD
Orphenadrine—Headache—Vinorelbine—breast cancer	6.09e-05	0.002	CcSEcCtD
Orphenadrine—Palpitations—Docetaxel—breast cancer	6e-05	0.00197	CcSEcCtD
Orphenadrine—CHRM2—endocrine gland—breast cancer	5.93e-05	0.0222	CbGeAlD
Orphenadrine—Hypersensitivity—Mitoxantrone—breast cancer	5.91e-05	0.00194	CcSEcCtD
Orphenadrine—Hypersensitivity—Irinotecan—breast cancer	5.91e-05	0.00194	CcSEcCtD
Orphenadrine—Vomiting—Thiotepa—breast cancer	5.91e-05	0.00194	CcSEcCtD
Orphenadrine—Drowsiness—Epirubicin—breast cancer	5.86e-05	0.00193	CcSEcCtD
Orphenadrine—Headache—Thiotepa—breast cancer	5.82e-05	0.00191	CcSEcCtD
Orphenadrine—Somnolence—Paclitaxel—breast cancer	5.82e-05	0.00191	CcSEcCtD
Orphenadrine—Palpitations—Capecitabine—breast cancer	5.81e-05	0.00191	CcSEcCtD
Orphenadrine—Nausea—Vinorelbine—breast cancer	5.78e-05	0.0019	CcSEcCtD
Orphenadrine—Bedaquiline—CYP3A4—breast cancer	5.76e-05	0.0319	CrCbGaD
Orphenadrine—Asthenia—Mitoxantrone—breast cancer	5.75e-05	0.00189	CcSEcCtD
Orphenadrine—Asthenia—Irinotecan—breast cancer	5.75e-05	0.00189	CcSEcCtD
Orphenadrine—Hypersensitivity—Fluorouracil—breast cancer	5.66e-05	0.00186	CcSEcCtD
Orphenadrine—SLC6A2—female reproductive system—breast cancer	5.64e-05	0.0211	CbGeAlD
Orphenadrine—KCNH2—uterus—breast cancer	5.63e-05	0.0211	CbGeAlD
Orphenadrine—Asthenia—Gemcitabine—breast cancer	5.61e-05	0.00184	CcSEcCtD
Orphenadrine—Constipation—Paclitaxel—breast cancer	5.59e-05	0.00184	CcSEcCtD
Orphenadrine—Confusional state—Docetaxel—breast cancer	5.59e-05	0.00184	CcSEcCtD
Orphenadrine—Anaphylactic shock—Docetaxel—breast cancer	5.54e-05	0.00182	CcSEcCtD
Orphenadrine—KCNH2—pituitary gland—breast cancer	5.53e-05	0.0207	CbGeAlD
Orphenadrine—Pruritus—Gemcitabine—breast cancer	5.53e-05	0.00182	CcSEcCtD
Orphenadrine—Nausea—Thiotepa—breast cancer	5.52e-05	0.00181	CcSEcCtD
Orphenadrine—SLC6A2—adrenal gland—breast cancer	5.5e-05	0.0206	CbGeAlD
Orphenadrine—HRH1—epithelium—breast cancer	5.46e-05	0.0204	CbGeAlD
Orphenadrine—Pruritus—Fluorouracil—breast cancer	5.44e-05	0.00178	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—breast cancer	5.43e-05	0.00178	CcSEcCtD
Orphenadrine—Confusional state—Capecitabine—breast cancer	5.41e-05	0.00178	CcSEcCtD
Orphenadrine—Tachycardia—Docetaxel—breast cancer	5.41e-05	0.00178	CcSEcCtD
Orphenadrine—Feeling abnormal—Paclitaxel—breast cancer	5.39e-05	0.00177	CcSEcCtD
Orphenadrine—Skin disorder—Docetaxel—breast cancer	5.39e-05	0.00177	CcSEcCtD
Orphenadrine—CYP2B6—skin of body—breast cancer	5.32e-05	0.0199	CbGeAlD
Orphenadrine—Dizziness—Irinotecan—breast cancer	5.3e-05	0.00174	CcSEcCtD
Orphenadrine—SCN10A—lymph node—breast cancer	5.3e-05	0.0198	CbGeAlD
Orphenadrine—Tachycardia—Capecitabine—breast cancer	5.24e-05	0.00172	CcSEcCtD
Orphenadrine—Skin disorder—Capecitabine—breast cancer	5.21e-05	0.00171	CcSEcCtD
Orphenadrine—Urticaria—Paclitaxel—breast cancer	5.2e-05	0.00171	CcSEcCtD
Orphenadrine—Vomiting—Mitoxantrone—breast cancer	5.1e-05	0.00167	CcSEcCtD
Orphenadrine—Vomiting—Irinotecan—breast cancer	5.1e-05	0.00167	CcSEcCtD
Orphenadrine—Dizziness—Fluorouracil—breast cancer	5.08e-05	0.00167	CcSEcCtD
Orphenadrine—KCNH2—female reproductive system—breast cancer	5.06e-05	0.0189	CbGeAlD
Orphenadrine—Headache—Mitoxantrone—breast cancer	5.02e-05	0.00165	CcSEcCtD
Orphenadrine—Headache—Irinotecan—breast cancer	5.02e-05	0.00165	CcSEcCtD
Orphenadrine—Vomiting—Gemcitabine—breast cancer	4.97e-05	0.00163	CcSEcCtD
Orphenadrine—KCNH2—adrenal gland—breast cancer	4.94e-05	0.0185	CbGeAlD
Orphenadrine—Somnolence—Docetaxel—breast cancer	4.93e-05	0.00162	CcSEcCtD
Orphenadrine—HRH1—endometrium—breast cancer	4.9e-05	0.0183	CbGeAlD
Orphenadrine—Headache—Gemcitabine—breast cancer	4.89e-05	0.00161	CcSEcCtD
Orphenadrine—Vomiting—Fluorouracil—breast cancer	4.88e-05	0.0016	CcSEcCtD
Orphenadrine—Hypersensitivity—Paclitaxel—breast cancer	4.82e-05	0.00158	CcSEcCtD
Orphenadrine—Headache—Fluorouracil—breast cancer	4.81e-05	0.00158	CcSEcCtD
Orphenadrine—KCNH2—bone marrow—breast cancer	4.78e-05	0.0179	CbGeAlD
Orphenadrine—SLC6A2—endocrine gland—breast cancer	4.77e-05	0.0179	CbGeAlD
Orphenadrine—Nausea—Irinotecan—breast cancer	4.76e-05	0.00156	CcSEcCtD
Orphenadrine—Nausea—Mitoxantrone—breast cancer	4.76e-05	0.00156	CcSEcCtD
Orphenadrine—Constipation—Docetaxel—breast cancer	4.74e-05	0.00156	CcSEcCtD
Orphenadrine—Asthenia—Paclitaxel—breast cancer	4.69e-05	0.00154	CcSEcCtD
Orphenadrine—Nausea—Gemcitabine—breast cancer	4.64e-05	0.00152	CcSEcCtD
Orphenadrine—Pruritus—Paclitaxel—breast cancer	4.63e-05	0.00152	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—breast cancer	4.61e-05	0.00152	CcSEcCtD
Orphenadrine—Toremifene—ESR1—breast cancer	4.61e-05	0.0255	CrCbGaD
Orphenadrine—KCNH2—female gonad—breast cancer	4.61e-05	0.0172	CbGeAlD
Orphenadrine—Constipation—Capecitabine—breast cancer	4.59e-05	0.00151	CcSEcCtD
Orphenadrine—Feeling abnormal—Docetaxel—breast cancer	4.57e-05	0.0015	CcSEcCtD
Orphenadrine—Nausea—Fluorouracil—breast cancer	4.56e-05	0.0015	CcSEcCtD
Orphenadrine—Tension—Epirubicin—breast cancer	4.5e-05	0.00148	CcSEcCtD
Orphenadrine—Feeling abnormal—Capecitabine—breast cancer	4.42e-05	0.00145	CcSEcCtD
Orphenadrine—HRH1—adipose tissue—breast cancer	4.42e-05	0.0165	CbGeAlD
Orphenadrine—Dizziness—Paclitaxel—breast cancer	4.33e-05	0.00142	CcSEcCtD
Orphenadrine—Vision blurred—Epirubicin—breast cancer	4.32e-05	0.00142	CcSEcCtD
Orphenadrine—KCNH2—endocrine gland—breast cancer	4.29e-05	0.016	CbGeAlD
Orphenadrine—Urticaria—Capecitabine—breast cancer	4.26e-05	0.0014	CcSEcCtD
Orphenadrine—Agitation—Epirubicin—breast cancer	4.21e-05	0.00138	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—breast cancer	4.16e-05	0.00137	CcSEcCtD
Orphenadrine—Vomiting—Paclitaxel—breast cancer	4.16e-05	0.00137	CcSEcCtD
Orphenadrine—CYP2B6—female reproductive system—breast cancer	4.16e-05	0.0156	CbGeAlD
Orphenadrine—Headache—Paclitaxel—breast cancer	4.1e-05	0.00135	CcSEcCtD
Orphenadrine—Hypersensitivity—Docetaxel—breast cancer	4.09e-05	0.00134	CcSEcCtD
Orphenadrine—HRH1—female reproductive system—breast cancer	4.06e-05	0.0152	CbGeAlD
Orphenadrine—CYP2B6—adrenal gland—breast cancer	4.06e-05	0.0152	CbGeAlD
Orphenadrine—Palpitations—Epirubicin—breast cancer	4.05e-05	0.00133	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—breast cancer	4.03e-05	0.00132	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—breast cancer	4e-05	0.00131	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—breast cancer	4e-05	0.00131	CcSEcCtD
Orphenadrine—Asthenia—Docetaxel—breast cancer	3.98e-05	0.00131	CcSEcCtD
Orphenadrine—HRH1—adrenal gland—breast cancer	3.96e-05	0.0148	CbGeAlD
Orphenadrine—Hypersensitivity—Capecitabine—breast cancer	3.96e-05	0.0013	CcSEcCtD
Orphenadrine—Ethopropazine—BCHE—breast cancer	3.94e-05	0.0218	CrCbGaD
Orphenadrine—Pruritus—Docetaxel—breast cancer	3.92e-05	0.00129	CcSEcCtD
Orphenadrine—CYP2E1—female reproductive system—breast cancer	3.9e-05	0.0146	CbGeAlD
Orphenadrine—Agitation—Doxorubicin—breast cancer	3.9e-05	0.00128	CcSEcCtD
Orphenadrine—Nausea—Paclitaxel—breast cancer	3.89e-05	0.00128	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—breast cancer	3.88e-05	0.00127	CcSEcCtD
Orphenadrine—Asthenia—Capecitabine—breast cancer	3.85e-05	0.00126	CcSEcCtD
Orphenadrine—CYP2E1—adrenal gland—breast cancer	3.81e-05	0.0142	CbGeAlD
Orphenadrine—Pruritus—Capecitabine—breast cancer	3.8e-05	0.00125	CcSEcCtD
Orphenadrine—Fenoprofen—PTGS1—breast cancer	3.8e-05	0.021	CrCbGaD
Orphenadrine—Confusional state—Epirubicin—breast cancer	3.77e-05	0.00124	CcSEcCtD
Orphenadrine—Palpitations—Doxorubicin—breast cancer	3.75e-05	0.00123	CcSEcCtD
Orphenadrine—Anaphylactic shock—Epirubicin—breast cancer	3.74e-05	0.00123	CcSEcCtD
Orphenadrine—HRH1—female gonad—breast cancer	3.69e-05	0.0138	CbGeAlD
Orphenadrine—Toremifene—CYP1A1—breast cancer	3.68e-05	0.0204	CrCbGaD
Orphenadrine—Dizziness—Docetaxel—breast cancer	3.67e-05	0.0012	CcSEcCtD
Orphenadrine—Tachycardia—Epirubicin—breast cancer	3.65e-05	0.0012	CcSEcCtD
Orphenadrine—Skin disorder—Epirubicin—breast cancer	3.63e-05	0.00119	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—breast cancer	3.55e-05	0.00117	CcSEcCtD
Orphenadrine—Dizziness—Capecitabine—breast cancer	3.55e-05	0.00117	CcSEcCtD
Orphenadrine—Vomiting—Docetaxel—breast cancer	3.53e-05	0.00116	CcSEcCtD
Orphenadrine—CYP2B6—endocrine gland—breast cancer	3.52e-05	0.0132	CbGeAlD
Orphenadrine—Confusional state—Doxorubicin—breast cancer	3.49e-05	0.00115	CcSEcCtD
Orphenadrine—Headache—Docetaxel—breast cancer	3.47e-05	0.00114	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—breast cancer	3.46e-05	0.00114	CcSEcCtD
Orphenadrine—Reboxetine—CYP2D6—breast cancer	3.46e-05	0.0191	CrCbGaD
Orphenadrine—HRH1—endocrine gland—breast cancer	3.44e-05	0.0129	CbGeAlD
Orphenadrine—Vomiting—Capecitabine—breast cancer	3.41e-05	0.00112	CcSEcCtD
Orphenadrine—Levomethadyl Acetate—CYP19A1—breast cancer	3.38e-05	0.0187	CrCbGaD
Orphenadrine—Tachycardia—Doxorubicin—breast cancer	3.38e-05	0.00111	CcSEcCtD
Orphenadrine—Headache—Capecitabine—breast cancer	3.36e-05	0.0011	CcSEcCtD
Orphenadrine—Skin disorder—Doxorubicin—breast cancer	3.36e-05	0.0011	CcSEcCtD
Orphenadrine—Somnolence—Epirubicin—breast cancer	3.32e-05	0.00109	CcSEcCtD
Orphenadrine—CYP2E1—endocrine gland—breast cancer	3.3e-05	0.0124	CbGeAlD
Orphenadrine—SLC6A2—lymph node—breast cancer	3.3e-05	0.0123	CbGeAlD
Orphenadrine—Nausea—Docetaxel—breast cancer	3.29e-05	0.00108	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—breast cancer	3.29e-05	0.00108	CcSEcCtD
Orphenadrine—Constipation—Epirubicin—breast cancer	3.2e-05	0.00105	CcSEcCtD
Orphenadrine—Nausea—Capecitabine—breast cancer	3.19e-05	0.00105	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—breast cancer	3.17e-05	0.00104	CcSEcCtD
Orphenadrine—CYP3A4—female reproductive system—breast cancer	3.14e-05	0.0117	CbGeAlD
Orphenadrine—Mepyramine—CYP2D6—breast cancer	3.08e-05	0.0171	CrCbGaD
Orphenadrine—Feeling abnormal—Epirubicin—breast cancer	3.08e-05	0.00101	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—breast cancer	3.08e-05	0.00101	CcSEcCtD
Orphenadrine—Tamoxifen—ESR2—breast cancer	2.99e-05	0.0165	CrCbGaD
Orphenadrine—Urticaria—Epirubicin—breast cancer	2.97e-05	0.000976	CcSEcCtD
Orphenadrine—Reboxetine—CYP3A4—breast cancer	2.97e-05	0.0164	CrCbGaD
Orphenadrine—KCNH2—lymph node—breast cancer	2.96e-05	0.0111	CbGeAlD
Orphenadrine—Constipation—Doxorubicin—breast cancer	2.96e-05	0.000972	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—breast cancer	2.94e-05	0.000967	CcSEcCtD
Orphenadrine—Asthenia—Methotrexate—breast cancer	2.87e-05	0.000942	CcSEcCtD
Orphenadrine—Tripelennamine—CYP2D6—breast cancer	2.85e-05	0.0158	CrCbGaD
Orphenadrine—Feeling abnormal—Doxorubicin—breast cancer	2.85e-05	0.000937	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—breast cancer	2.83e-05	0.000929	CcSEcCtD
Orphenadrine—Aprindine—CYP2D6—breast cancer	2.79e-05	0.0154	CrCbGaD
Orphenadrine—Hypersensitivity—Epirubicin—breast cancer	2.76e-05	0.000905	CcSEcCtD
Orphenadrine—Urticaria—Doxorubicin—breast cancer	2.75e-05	0.000903	CcSEcCtD
Orphenadrine—Tamoxifen—CYP1B1—breast cancer	2.73e-05	0.0151	CrCbGaD
Orphenadrine—Asthenia—Epirubicin—breast cancer	2.68e-05	0.000881	CcSEcCtD
Orphenadrine—CYP3A4—endocrine gland—breast cancer	2.66e-05	0.00994	CbGeAlD
Orphenadrine—Warfarin—CYP1A1—breast cancer	2.66e-05	0.0147	CrCbGaD
Orphenadrine—Pruritus—Epirubicin—breast cancer	2.65e-05	0.000869	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—breast cancer	2.64e-05	0.000868	CcSEcCtD
Orphenadrine—Hypersensitivity—Doxorubicin—breast cancer	2.55e-05	0.000837	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—breast cancer	2.54e-05	0.000834	CcSEcCtD
Orphenadrine—Headache—Methotrexate—breast cancer	2.5e-05	0.000822	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—breast cancer	2.48e-05	0.000815	CcSEcCtD
Orphenadrine—Dizziness—Epirubicin—breast cancer	2.47e-05	0.000812	CcSEcCtD
Orphenadrine—Reboxetine—ABCB1—breast cancer	2.47e-05	0.0137	CrCbGaD
Orphenadrine—Pruritus—Doxorubicin—breast cancer	2.45e-05	0.000804	CcSEcCtD
Orphenadrine—Vomiting—Epirubicin—breast cancer	2.38e-05	0.000781	CcSEcCtD
Orphenadrine—HRH1—lymph node—breast cancer	2.37e-05	0.00888	CbGeAlD
Orphenadrine—Nausea—Methotrexate—breast cancer	2.37e-05	0.00078	CcSEcCtD
Orphenadrine—Cyclobenzaprine—CYP2D6—breast cancer	2.37e-05	0.0131	CrCbGaD
Orphenadrine—Toremifene—CYP3A4—breast cancer	2.35e-05	0.013	CrCbGaD
Orphenadrine—Headache—Epirubicin—breast cancer	2.34e-05	0.000769	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—breast cancer	2.29e-05	0.000752	CcSEcCtD
Orphenadrine—Tolterodine—CYP2D6—breast cancer	2.27e-05	0.0126	CrCbGaD
Orphenadrine—Nausea—Epirubicin—breast cancer	2.22e-05	0.00073	CcSEcCtD
Orphenadrine—Alimemazine—CYP3A4—breast cancer	2.21e-05	0.0122	CrCbGaD
Orphenadrine—Vomiting—Doxorubicin—breast cancer	2.2e-05	0.000723	CcSEcCtD
Orphenadrine—Benzatropine—CYP2D6—breast cancer	2.19e-05	0.0121	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—breast cancer	2.17e-05	0.012	CrCbGaD
Orphenadrine—Headache—Doxorubicin—breast cancer	2.17e-05	0.000712	CcSEcCtD
Orphenadrine—Fluoxetine—CYP2D6—breast cancer	2.17e-05	0.012	CrCbGaD
Orphenadrine—Nausea—Doxorubicin—breast cancer	2.06e-05	0.000675	CcSEcCtD
Orphenadrine—Cyclobenzaprine—CYP3A4—breast cancer	2.03e-05	0.0113	CrCbGaD
Orphenadrine—Tamoxifen—CYP19A1—breast cancer	2e-05	0.0111	CrCbGaD
Orphenadrine—Methadone—CYP19A1—breast cancer	1.98e-05	0.011	CrCbGaD
Orphenadrine—Toremifene—ABCB1—breast cancer	1.96e-05	0.0108	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2D6—breast cancer	1.95e-05	0.0108	CrCbGaD
Orphenadrine—Tolterodine—CYP3A4—breast cancer	1.95e-05	0.0108	CrCbGaD
Orphenadrine—Fenoprofen—ALB—breast cancer	1.93e-05	0.0107	CrCbGaD
Orphenadrine—Phenprocoumon—CYP3A4—breast cancer	1.91e-05	0.0106	CrCbGaD
Orphenadrine—Tamoxifen—ABCG2—breast cancer	1.88e-05	0.0104	CrCbGaD
Orphenadrine—Fluoxetine—CYP3A4—breast cancer	1.86e-05	0.0103	CrCbGaD
Orphenadrine—Tamoxifen—ESR1—breast cancer	1.84e-05	0.0102	CrCbGaD
Orphenadrine—Warfarin—CYP3A4—breast cancer	1.7e-05	0.00938	CrCbGaD
Orphenadrine—Brompheniramine—CYP2D6—breast cancer	1.69e-05	0.00935	CrCbGaD
Orphenadrine—Carbinoxamine—CYP3A4—breast cancer	1.67e-05	0.00925	CrCbGaD
Orphenadrine—Phenprocoumon—ALB—breast cancer	1.67e-05	0.00923	CrCbGaD
Orphenadrine—Chlorphenamine—CYP2D6—breast cancer	1.66e-05	0.00917	CrCbGaD
Orphenadrine—Diphenhydramine—PTGS1—breast cancer	1.65e-05	0.00915	CrCbGaD
Orphenadrine—Fluoxetine—ALB—breast cancer	1.62e-05	0.00898	CrCbGaD
Orphenadrine—Dextropropoxyphene—CYP2D6—breast cancer	1.6e-05	0.00886	CrCbGaD
Orphenadrine—Levomethadyl Acetate—CYP3A4—breast cancer	1.59e-05	0.00879	CrCbGaD
Orphenadrine—Fluoxetine—ABCB1—breast cancer	1.55e-05	0.00857	CrCbGaD
Orphenadrine—Warfarin—ALB—breast cancer	1.48e-05	0.00819	CrCbGaD
Orphenadrine—Tamoxifen—CYP1A1—breast cancer	1.47e-05	0.00814	CrCbGaD
Orphenadrine—Brompheniramine—CYP3A4—breast cancer	1.45e-05	0.00802	CrCbGaD
Orphenadrine—Chlorphenamine—CYP3A4—breast cancer	1.42e-05	0.00787	CrCbGaD
Orphenadrine—Atomoxetine—CYP2D6—breast cancer	1.39e-05	0.00771	CrCbGaD
Orphenadrine—Modafinil—CYP3A4—breast cancer	1.39e-05	0.00769	CrCbGaD
Orphenadrine—Dextropropoxyphene—CYP3A4—breast cancer	1.37e-05	0.0076	CrCbGaD
Orphenadrine—Benzphetamine—CYP3A4—breast cancer	1.2e-05	0.00666	CrCbGaD
Orphenadrine—Atomoxetine—CYP3A4—breast cancer	1.19e-05	0.00661	CrCbGaD
Orphenadrine—Phenoxybenzamine—CYP3A4—breast cancer	1.15e-05	0.00637	CrCbGaD
Orphenadrine—Trimipramine—CYP2D6—breast cancer	1.15e-05	0.00634	CrCbGaD
Orphenadrine—Diphenhydramine—CYP2D6—breast cancer	1.12e-05	0.00623	CrCbGaD
Orphenadrine—Promethazine—CYP2D6—breast cancer	1.1e-05	0.0061	CrCbGaD
Orphenadrine—Tamoxifen—CYP2D6—breast cancer	1.1e-05	0.00606	CrCbGaD
Orphenadrine—Doxepin—CYP2D6—breast cancer	1.09e-05	0.00604	CrCbGaD
Orphenadrine—Methadone—CYP2D6—breast cancer	1.09e-05	0.00601	CrCbGaD
Orphenadrine—Trimipramine—CYP3A4—breast cancer	9.83e-06	0.00544	CrCbGaD
Orphenadrine—Tamoxifen—CYP3A4—breast cancer	9.39e-06	0.0052	CrCbGaD
Orphenadrine—Doxepin—CYP3A4—breast cancer	9.36e-06	0.00518	CrCbGaD
Orphenadrine—Methadone—CYP3A4—breast cancer	9.31e-06	0.00515	CrCbGaD
Orphenadrine—Imipramine—CYP2D6—breast cancer	8.5e-06	0.0047	CrCbGaD
Orphenadrine—Amitriptyline—CYP2D6—breast cancer	8.44e-06	0.00467	CrCbGaD
Orphenadrine—Promazine—CYP3A4—breast cancer	8.32e-06	0.00461	CrCbGaD
Orphenadrine—Trimipramine—ABCB1—breast cancer	8.18e-06	0.00453	CrCbGaD
Orphenadrine—Promethazine—ABCB1—breast cancer	7.88e-06	0.00436	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—breast cancer	7.82e-06	0.00433	CrCbGaD
Orphenadrine—Doxepin—ABCB1—breast cancer	7.8e-06	0.00431	CrCbGaD
Orphenadrine—Methadone—ABCB1—breast cancer	7.75e-06	0.00429	CrCbGaD
Orphenadrine—Imipramine—CYP3A4—breast cancer	7.29e-06	0.00403	CrCbGaD
Orphenadrine—Amitriptyline—CYP3A4—breast cancer	7.24e-06	0.00401	CrCbGaD
Orphenadrine—Amitriptyline—ALB—breast cancer	6.32e-06	0.0035	CrCbGaD
Orphenadrine—Imipramine—ABCB1—breast cancer	6.07e-06	0.00336	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—breast cancer	6.03e-06	0.00334	CrCbGaD
Orphenadrine—HRH1—Signaling Pathways—SMAD4—breast cancer	1.43e-06	3.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—breast cancer	1.42e-06	3.79e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PLA2G4A—breast cancer	1.42e-06	3.79e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—breast cancer	1.42e-06	3.79e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NCOR1—breast cancer	1.42e-06	3.79e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	1.42e-06	3.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SMAD4—breast cancer	1.41e-06	3.76e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TYMS—breast cancer	1.41e-06	3.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA9—breast cancer	1.41e-06	3.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA4—breast cancer	1.41e-06	3.75e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—breast cancer	1.4e-06	3.73e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HES1—breast cancer	1.4e-06	3.73e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	1.39e-06	3.72e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—breast cancer	1.39e-06	3.71e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PLA2G4A—breast cancer	1.39e-06	3.71e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NCOR1—breast cancer	1.39e-06	3.71e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	1.39e-06	3.71e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NCOR1—breast cancer	1.39e-06	3.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HES1—breast cancer	1.37e-06	3.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CSF2—breast cancer	1.37e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF1—breast cancer	1.37e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RAF1—breast cancer	1.37e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA2—breast cancer	1.37e-06	3.65e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX2—breast cancer	1.37e-06	3.65e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NCOR1—breast cancer	1.37e-06	3.65e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	1.37e-06	3.65e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NRG1—breast cancer	1.36e-06	3.64e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—breast cancer	1.36e-06	3.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—H2AFX—breast cancer	1.35e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—breast cancer	1.35e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SULT1A1—breast cancer	1.35e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX4—breast cancer	1.35e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF1—breast cancer	1.35e-06	3.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CSF2—breast cancer	1.35e-06	3.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RAF1—breast cancer	1.35e-06	3.6e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A1—breast cancer	1.35e-06	3.59e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—E2F1—breast cancer	1.34e-06	3.59e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NRG1—breast cancer	1.34e-06	3.58e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	1.34e-06	3.57e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ERCC2—breast cancer	1.34e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—H2AFX—breast cancer	1.33e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—breast cancer	1.33e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—breast cancer	1.33e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—E2F1—breast cancer	1.32e-06	3.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—IDH1—breast cancer	1.32e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA1—breast cancer	1.32e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A1—breast cancer	1.32e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	1.32e-06	3.51e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ERCC2—breast cancer	1.31e-06	3.49e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NAT2—breast cancer	1.31e-06	3.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPP1—breast cancer	1.29e-06	3.44e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—breast cancer	1.29e-06	3.43e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB3—breast cancer	1.28e-06	3.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGFR2—breast cancer	1.28e-06	3.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPP1—breast cancer	1.27e-06	3.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	1.27e-06	3.37e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB3—breast cancer	1.26e-06	3.35e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—breast cancer	1.26e-06	3.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGFR2—breast cancer	1.26e-06	3.35e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—breast cancer	1.23e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—breast cancer	1.23e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TERT—breast cancer	1.22e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—breast cancer	1.21e-06	3.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TERT—breast cancer	1.2e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGFR1—breast cancer	1.19e-06	3.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HIF1A—breast cancer	1.17e-06	3.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGFR1—breast cancer	1.17e-06	3.12e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAV1—breast cancer	1.16e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HIF1A—breast cancer	1.15e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MED12—breast cancer	1.15e-06	3.06e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DPYD—breast cancer	1.15e-06	3.06e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—breast cancer	1.14e-06	3.05e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAV1—breast cancer	1.13e-06	3.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CAV1—breast cancer	1.13e-06	3.02e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDOA—breast cancer	1.13e-06	3.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—breast cancer	1.12e-06	3e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KDR—breast cancer	1.12e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CAV1—breast cancer	1.11e-06	2.97e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KDR—breast cancer	1.1e-06	2.94e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOA3—breast cancer	1.1e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—breast cancer	1.09e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A2—breast cancer	1.09e-06	2.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FN1—breast cancer	1.08e-06	2.87e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—breast cancer	1.07e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CPT1A—breast cancer	1.07e-06	2.84e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG2—breast cancer	1.07e-06	2.84e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTR—breast cancer	1.07e-06	2.84e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKBIA—breast cancer	1.07e-06	2.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FN1—breast cancer	1.06e-06	2.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH1—breast cancer	1.05e-06	2.81e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CG—breast cancer	1.05e-06	2.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	1.05e-06	2.8e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HPGDS—breast cancer	1.04e-06	2.79e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HBA1—breast cancer	1.04e-06	2.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	1.04e-06	2.77e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CG—breast cancer	1.03e-06	2.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APC—breast cancer	1.03e-06	2.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CG—breast cancer	1.03e-06	2.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KIT—breast cancer	1.03e-06	2.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGF—breast cancer	1.02e-06	2.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	1.02e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KIT—breast cancer	1.02e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APC—breast cancer	1.02e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACHE—breast cancer	1.01e-06	2.7e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—breast cancer	1.01e-06	2.7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGF—breast cancer	1e-06	2.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—breast cancer	9.88e-07	2.63e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	9.72e-07	2.59e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BRAF—breast cancer	9.7e-07	2.59e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP17A1—breast cancer	9.59e-07	2.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BRAF—breast cancer	9.54e-07	2.54e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO1—breast cancer	9.49e-07	2.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS1—breast cancer	9.49e-07	2.53e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—breast cancer	9.45e-07	2.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT2—breast cancer	9.44e-07	2.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—breast cancer	9.4e-07	2.51e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2D6—breast cancer	9.31e-07	2.48e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—breast cancer	9.29e-07	2.48e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT2—breast cancer	9.29e-07	2.48e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CD—breast cancer	9.27e-07	2.47e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—breast cancer	9.25e-07	2.47e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—breast cancer	9.15e-07	2.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOA2—breast cancer	9.14e-07	2.44e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CD—breast cancer	9.08e-07	2.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CD—breast cancer	9.07e-07	2.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	8.98e-07	2.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SERPINE1—breast cancer	8.97e-07	2.39e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—breast cancer	8.96e-07	2.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	8.92e-07	2.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—breast cancer	8.88e-07	2.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—FASN—breast cancer	8.86e-07	2.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	8.84e-07	2.36e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BCHE—breast cancer	8.83e-07	2.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	8.83e-07	2.35e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NOS3—breast cancer	8.75e-07	2.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—breast cancer	8.74e-07	2.33e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC5A5—breast cancer	8.72e-07	2.33e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NOS3—breast cancer	8.57e-07	2.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOS3—breast cancer	8.56e-07	2.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOS3—breast cancer	8.43e-07	2.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NQO1—breast cancer	8.42e-07	2.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A1—breast cancer	8.42e-07	2.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	8.16e-07	2.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MDM2—breast cancer	8.12e-07	2.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAF1—breast cancer	8.1e-07	2.16e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CB—breast cancer	8.08e-07	2.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1B1—breast cancer	8.07e-07	2.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RELA—breast cancer	8.06e-07	2.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	8.03e-07	2.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—breast cancer	8.01e-07	2.14e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—breast cancer	8.01e-07	2.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MDM2—breast cancer	7.99e-07	2.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAF1—breast cancer	7.97e-07	2.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RELA—breast cancer	7.93e-07	2.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSP90AA1—breast cancer	7.92e-07	2.11e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CB—breast cancer	7.91e-07	2.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CB—breast cancer	7.9e-07	2.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MTOR—breast cancer	7.9e-07	2.11e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—breast cancer	7.88e-07	2.1e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—breast cancer	7.84e-07	2.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MTOR—breast cancer	7.78e-07	2.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	7.78e-07	2.07e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOA1—breast cancer	7.7e-07	2.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—breast cancer	7.6e-07	2.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—STK11—breast cancer	7.59e-07	2.02e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP19A1—breast cancer	7.59e-07	2.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—breast cancer	7.55e-07	2.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—breast cancer	7.47e-07	1.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—breast cancer	7.43e-07	1.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1B—breast cancer	7.42e-07	1.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—breast cancer	7.34e-07	1.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	7.3e-07	1.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—breast cancer	7.27e-07	1.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—breast cancer	7.26e-07	1.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—breast cancer	7.22e-07	1.93e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	7.22e-07	1.93e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—breast cancer	7.15e-07	1.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—breast cancer	7.14e-07	1.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—breast cancer	7.11e-07	1.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—breast cancer	7.08e-07	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUN—breast cancer	7.06e-07	1.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—COMT—breast cancer	7.06e-07	1.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—breast cancer	7.02e-07	1.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNB1—breast cancer	7.01e-07	1.87e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—breast cancer	6.98e-07	1.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—breast cancer	6.96e-07	1.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUN—breast cancer	6.95e-07	1.85e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—breast cancer	6.93e-07	1.85e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ITPR1—breast cancer	6.91e-07	1.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	6.9e-07	1.84e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—breast cancer	6.87e-07	1.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1A—breast cancer	6.85e-07	1.83e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—breast cancer	6.84e-07	1.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—breast cancer	6.83e-07	1.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—breast cancer	6.76e-07	1.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	6.74e-07	1.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—breast cancer	6.72e-07	1.79e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK8—breast cancer	6.68e-07	1.78e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—breast cancer	6.66e-07	1.78e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—breast cancer	6.65e-07	1.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK8—breast cancer	6.57e-07	1.75e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—breast cancer	6.56e-07	1.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TYMS—breast cancer	6.53e-07	1.74e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOR1—breast cancer	6.45e-07	1.72e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—breast cancer	6.45e-07	1.72e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.45e-07	1.72e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SRC—breast cancer	6.33e-07	1.69e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SRC—breast cancer	6.23e-07	1.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—breast cancer	6.18e-07	1.65e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—breast cancer	6.17e-07	1.65e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A1—breast cancer	6.12e-07	1.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—breast cancer	6.11e-07	1.63e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—breast cancer	6.07e-07	1.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ERCC2—breast cancer	6.07e-07	1.62e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—breast cancer	6.01e-07	1.6e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—breast cancer	5.84e-07	1.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—breast cancer	5.74e-07	1.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—breast cancer	5.7e-07	1.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—breast cancer	5.68e-07	1.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—breast cancer	5.66e-07	1.51e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—breast cancer	5.59e-07	1.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—breast cancer	5.57e-07	1.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—breast cancer	5.55e-07	1.48e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—breast cancer	5.46e-07	1.46e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAV1—breast cancer	5.26e-07	1.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—breast cancer	5.24e-07	1.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—breast cancer	5.16e-07	1.38e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—breast cancer	4.93e-07	1.31e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—breast cancer	4.82e-07	1.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—breast cancer	4.82e-07	1.29e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CG—breast cancer	4.79e-07	1.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	4.74e-07	1.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—breast cancer	4.66e-07	1.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—breast cancer	4.59e-07	1.22e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—breast cancer	4.46e-07	1.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—breast cancer	4.39e-07	1.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—breast cancer	4.27e-07	1.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CD—breast cancer	4.21e-07	1.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—breast cancer	4.2e-07	1.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—breast cancer	4.16e-07	1.11e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—breast cancer	4.02e-07	1.07e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NOS3—breast cancer	3.98e-07	1.06e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—breast cancer	3.94e-07	1.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—breast cancer	3.94e-07	1.05e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—breast cancer	3.87e-07	1.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CB—breast cancer	3.67e-07	9.79e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—breast cancer	3.64e-07	9.7e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—breast cancer	3.17e-07	8.46e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.24e-07	5.97e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—breast cancer	1.83e-07	4.88e-06	CbGpPWpGaD
